The Preclinical Imaging market is a subset of the Drug Discovery market, which focuses on the development of new drugs and treatments. Preclinical Imaging is the use of imaging technologies to study the effects of drugs on living organisms. This includes techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET). These technologies allow researchers to observe the effects of drugs on the body in real-time, providing valuable insights into the efficacy and safety of potential treatments. Preclinical Imaging is used to assess the safety and efficacy of drugs before they are tested in clinical trials. Some companies in the Preclinical Imaging market include Bruker, Siemens Healthineers, Canon Medical Systems, Philips Healthcare, and GE Healthcare. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
